Jiangsu Hengrui Medicine Co., Ltd.

This study is testing if adding a new drug called SHR4640 to a standard gout medication (febuxostat) works better for lowering uric acid than simply increasing the dose of the standard drug alone. It will involve about 340 adults with gout whose uric acid is still too high despit…

This study is testing whether hetrombopag tablets can help cancer patients maintain safe platelet levels during chemotherapy. Researchers want to see if this medication allows patients to complete their chemotherapy cycles without dangerous drops in platelets that often cause tre…

This early-stage study is testing a new drug called SHR-4394 when given alongside other prostate cancer treatments. Researchers want to find the safest and most effective dose and see if the combination helps control the cancer. The trial will enroll about 100 men with advanced p…

This is the first study in people to test a new drug called SHR-1049 injection for patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, check for side effects, and see how the body processes the drug. Res…

This major study is testing if adding a new drug called HRS-4642 to standard chemotherapy works better than chemotherapy alone for people with advanced pancreatic cancer that has a specific genetic change (KRAS G12D mutation). About 588 participants will be randomly assigned to r…

This early-stage clinical trial is testing a new drug called HRS-8364 in adults with advanced solid tumors that have progressed despite standard treatments. The study aims to find a safe and effective dose and see if the drug can shrink tumors. It will enroll up to 282 participan…

This study is testing a new drug called SHR-3167 for adults whose type 2 diabetes isn't well-managed with current pills. It will compare two methods for adjusting the drug dose: a standard fixed plan and a plan tailored to each person. The main goal is to see which method is safe…

This study is testing a new muscle relaxant called HRS-9190 against a standard medication during surgery. Researchers want to see how well it works and how safe it is for keeping muscles relaxed while patients are under anesthesia. The study will include 60 adults having planned …

This is an early safety study to see how two slightly different versions of an experimental injection for diabetes are absorbed by the body. It will involve 60 healthy volunteers to measure drug levels in the blood and check for any side effects. The main goal is to gather basic …

This early-stage study aims to understand what happens to a new drug, HRS-9190, after it's given to people. Six healthy male volunteers will receive a single dose containing a tiny, safe amount of radioactive tracer. Researchers will then carefully measure how the drug is absorbe…